Astrocytoma

Study of Olutasidenib and Temozolomide in HGG

Pediatric Long-Term Follow-up and Rollover Study

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

Investigational Imaging Technique During Brain Surgery

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Tuvusertib in Astrocytoma With ATRX Mutation

Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases

Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

Venous Thromboembolism Prevention in Outpatients With Glioma

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial

Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas